Veronica S Gil

5PUBLICATIONS
53CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|May 13, 2022
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer.

Beshara Sheehan, Antje Neeb, Lorenzo Buroni

|Nov 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer.

Veronica Gil, Susana Miranda, Ruth Riisnaes

|Apr 06, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.

Alec Paschalis, Jonathan Welti, Antje J Neeb

|Jan 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Jonathan Welti, Adam Sharp, Nigel Brooks

Pageof 1